Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Apixaban

An oral anticoagulant that directly inhibits coagulation factor Xa, approved in Europe in 2011. It is used to prevent strokes and thrombosis, for example in atrial fibrillation and after hip or knee replacement. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Only about a quarter of the dose is cleared by the kidneys: among the new oral anticoagulants it is the one that depends least on kidney function.

ApixabanGo to the active ingredient →
ApixabanActive ingredientApixabanCat. No. P-A172-001CAS 503612-47-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.